Combination therapy of pegylated alpha 2a interferon and ribavirin is currently the most successful treatment of patients with chronic hepatitis C. However the patients must be monitored closely, as this therapy can lead to serious ocular and systemic side effects. Here, IFNA2 is linked to chronic hepatitis C virus infection.